Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jamieson Wellness Inc ( (TSE:JWEL) ) has issued an update.
Jamieson Wellness Inc. announced it will release its second quarter 2025 financial results on August 7, 2025, followed by a conference call for investors. This announcement is significant as it provides stakeholders an opportunity to gain insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.
Spark’s Take on TSE:JWEL Stock
According to Spark, TipRanks’ AI Analyst, TSE:JWEL is a Outperform.
Jamieson Wellness Inc. demonstrates robust financial performance and bullish technical indicators, supporting a strong stock score. The premium valuation suggests high market expectations, while positive corporate events further bolster investor confidence.
To see Spark’s full report on TSE:JWEL stock, click here.
More about Jamieson Wellness Inc
Jamieson Wellness Inc. is a leading company in the natural health industry, known for its innovative portfolio of vitamins, minerals, and supplements (VMS). Established in 1922, it holds the position of Canada’s top VMS brand and has expanded its reach with the acquisition of the youtheory brand in 2022, enhancing its presence in the U.S. market. The company’s products are available in over 50 countries, and it also offers sports nutrition products under various brands in Canada. Jamieson Wellness is committed to responsible business practices as a participant in the United Nations Global Compact.
Average Trading Volume: 49,179
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$1.43B
Find detailed analytics on JWEL stock on TipRanks’ Stock Analysis page.